Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
---|
12/27/1995 | EP0688866A1 Thermostable trehalose-releasing enzyme, and its preparation and uses |
12/27/1995 | EP0688565A1 Tablet, capsule, or granule comprising desogestrel |
12/27/1995 | EP0688564A2 Method of controlling release of an active or drug from a silicone rubber matrix |
12/27/1995 | EP0688429A1 Macromolecular microparticles and methods of production |
12/27/1995 | EP0688329A1 Novel phospholipid-saccharide conjugates |
12/27/1995 | EP0688327A1 Analogs for specific oligosaccharide-protein interactions and uses therefor |
12/27/1995 | EP0688229A1 Use of low density lipoprotein with cytotoxic substances |
12/27/1995 | EP0688207A1 Lipid-polymer conjugates and liposomes |
12/27/1995 | EP0688205A1 Polymeric mucoadhesives in the delivery of immunogens at mucosal surfaces |
12/27/1995 | EP0688166A1 Proteinaceous oil spill dispersant |
12/27/1995 | EP0646002B1 Preparation and use of novel cyclodextrin-based dispersible nanovesicular colloidal systems in the form of nanocapsules |
12/27/1995 | EP0578726B1 Virus inactivation method |
12/27/1995 | CN1113955A Medicinal leather and its making method |
12/27/1995 | CN1113698A Amorphophallus rivieri fine flour |
12/26/1995 | US5478829 Solution of sparfloxacin, its preparation and salt of which it is composed |
12/26/1995 | US5478806 Enhancement of antitumor therapy with hemoglobin-based conjugates |
12/26/1995 | US5478805 Fractionation of polyalkylene oxide-conjugated hemoglobin solutions |
12/26/1995 | US5478804 Administering cytotoxic conjugates which target tumor cells expressing fibroblast growth factor receptors |
12/26/1995 | US5478593 Applying a polyol syrup such as sorbitol or maltitol followed by application in powder form; carried out without forced drying; chewing gums |
12/26/1995 | US5478578 Micronized active material, excipient mixture with fine and coarse particles |
12/26/1995 | US5478577 Administering controlled release dosage form of opiate analgesics |
12/26/1995 | US5478576 Arabinogalactan derivatives and uses thereof |
12/26/1995 | US5478575 Polymers having benzeneboronic acid groups and insulin complexes of same of a sugar response type |
12/26/1995 | US5478574 Agglomerated hydrophilic complexes with multi-phasic release characteristics |
12/26/1995 | US5478573 Delayed, sustained-release propranolol pharmaceutical preparation |
12/26/1995 | US5478572 Cellulosic polymer matrix and excipients; extended release; side effect reduction; antidepressants and anxiolytic agents |
12/26/1995 | US5478571 Process for the preparation of substantially alcohol free pharmaceutical compositions |
12/26/1995 | US5478569 Cold water dispersible particles of fat-soluble substance encapsulated with protective fish gelatin colloid; nutritional supplements |
12/26/1995 | US5478567 Drug, such as ketoprofen, rosin solubiizer, polymer, softener polyester cloth backing |
12/26/1995 | CA1337797C Medicated cleansing pads |
12/26/1995 | CA1337796C Plasminogen activator-heparin conjugates |
12/21/1995 | WO1995034665A2 Chimerical peptide-nucleic acid fragment, process for producing the same and its use for appropriately introducing nucleic acids into cell organelles and cells |
12/21/1995 | WO1995034647A1 Compositions for and methods of enhancing delivery of nucleic acids to cells |
12/21/1995 | WO1995034595A1 Antiviral dendrimers |
12/21/1995 | WO1995034582A1 Bioadhesive starches and process for their preparation |
12/21/1995 | WO1995034533A1 Water-soluble nimesulide salt, and uses thereof for the treatment of inflammations |
12/21/1995 | WO1995034528A1 Polyolpolyhydroxystearates |
12/21/1995 | WO1995034328A1 A bio-erodible matrix for the controlled release of medicinals and the assay of hydrolytic enzymes |
12/21/1995 | WO1995034326A1 Pegylation reagents and compounds formed therewith |
12/21/1995 | WO1995034325A1 Delivery of therapeutic agents to receptors using polysaccharides |
12/21/1995 | WO1995034318A1 Solution comprising igf-i or any functional analogue thereof and method for its preparation |
12/21/1995 | WO1995034308A2 Adjuvant compositions comprising a mineral salt and another immunostimulating compound |
12/21/1995 | WO1995034302A2 Method for reducing intraocular pressure in the mammalian eye by administration of calcium chelators |
12/21/1995 | WO1995034295A1 A novel method for importing biologically active molecules into cells |
12/21/1995 | WO1995034287A1 Lipid based composition containing diacylglycerol, phospholipid, polar liquid and biologically active material |
12/21/1995 | WO1995030423A3 Cancer treatment and metastasis prevention |
12/21/1995 | WO1995024430A3 Block and graft copolymers and methods relating thereto |
12/21/1995 | CA2192541A1 A bio-erodible matrix for the controlled release of medicinals and the assay of hydrolytic enzymes |
12/21/1995 | CA2169747A1 Water-soluble nimesulide salt, and uses thereof for the treatment of inflammations |
12/20/1995 | EP0687473A1 Optical isomerization inhibitor |
12/20/1995 | EP0687464A2 Process for manufacturing effervescent tablets and effervescent tablets |
12/20/1995 | EP0687174A1 Crystalline cyclodextrin inclusion complexes of ranitidine hydrochloride and process for their preparation |
12/20/1995 | EP0687171A1 Use of trans-urocanic acid as an antioxidant and for the prophylaxis and treatment of ageing of the skin |
12/20/1995 | EP0645997B1 Cosmetic containing phospholipids and fluorocarbon compounds |
12/20/1995 | EP0596049A4 Defoaming composition |
12/20/1995 | EP0576585B1 Viscous surface active composition |
12/20/1995 | EP0553169B1 A method for drug formulation and a pharmaceutical composition |
12/20/1995 | EP0525063B1 Use of specific fatty acids in the manufacture of a medicament for their Iontophoresis delivery |
12/20/1995 | EP0514523B1 Method for making liposomes of enhanced entrapping capacity toward foreign substances to be encapsulated |
12/20/1995 | EP0494996B1 Erodible macroporous hydrogel particles and preparation thereof |
12/20/1995 | EP0180581B2 Drug preparations of reduced toxicity |
12/19/1995 | US5476852 Method of topically treating acne vulgaris, hyperkeratotic dermatoses, and photo-aging of the skin |
12/19/1995 | US5476843 Stable topical formulations with good active ingredient release characteristics, containing at least one lipophilized macrolide antibiotic |
12/19/1995 | US5476842 Administering conjugate of cytotoxic phenolic compounds and mono- or disaccharides; damages cancer cells |
12/19/1995 | US5476782 DNA encoding a human 5-HT1E receptor and uses thereof |
12/19/1995 | US5476667 Method for drug formulation and a pharmaceutical composition |
12/19/1995 | US5476666 Glycosaminoglycan-synthetic polymer conjugates |
12/19/1995 | US5476665 Azlactone functional particles incorporated in a membrane formed by solvent phase inversion |
12/19/1995 | US5476659 Killing; particularly lymphocytic leukemia |
12/19/1995 | US5476654 Preparing tablets by mixing terfenadine with a cross-linked sodium carboxymethyl cellulose and a hydrophilic polymer which gels with water |
12/19/1995 | US5476653 Polyoxymethylene-oxyethylene copolymers in conjuction with biomolecules |
12/19/1995 | US5476648 Oil in water emulsions |
12/19/1995 | US5476646 Gastrointestinal tract |
12/14/1995 | WO1995033835A1 Nucleic acid immunization using a virus-based infection/transfection system |
12/14/1995 | WO1995033773A1 Lysozyme-degradable biomaterials |
12/14/1995 | WO1995033766A1 Branched synthetic peptide conjugate |
12/14/1995 | WO1995033554A1 Use of a polymer material based on modified hydrocolloids as encapsulating material |
12/14/1995 | WO1995033492A1 Methods and compositions for modulation of wound healing |
12/14/1995 | WO1995033491A1 Biotin compounds for targetting tumors and sites of infection |
12/14/1995 | WO1995033490A1 Method of solubilizing substantially water insoluble materials |
12/14/1995 | WO1995033489A1 Stable gel formulation for topical treatment of skin conditions |
12/14/1995 | WO1995033488A1 Method of preventing aggregation of various substances upon rehydration or thawing and compositions obtained thereby |
12/14/1995 | WO1995033487A1 Injectable formulations containing a desiccant |
12/14/1995 | WO1995033481A1 Diphtheria toxin vaccines bearing a mutated r domain |
12/14/1995 | WO1995033474A1 Medicinal composition |
12/14/1995 | WO1995033452A1 Volume-expandable flat article suitable for use as an active substance carrier, in particular for oral use |
12/14/1995 | WO1995033450A1 Starch acetate composition with modifiable properties, method for preparation and usage thereof |
12/14/1995 | WO1995033447A1 Stable reverse and multiple fluorocarbon emulsions |
12/14/1995 | DE4420516A1 Polyolpolyhydroxystearate Polyolpolyhydroxystearates |
12/14/1995 | DE4419824A1 Volumen-expandierbares, als Wirkstoffträger insbesondere zur oralen Anwendung geeignete flächige Anwendungsform Volume expandable as drug carriers particularly suitable for oral application area application form |
12/14/1995 | CA2192384A1 Biotin compounds for targetting tumors and sites of infection |
12/14/1995 | CA2192200A1 Volume-expandable flat article suitable for use as an active substance carrier, in particular for oral use |
12/14/1995 | CA2191753A1 Lysozyme-degradable biomaterials |
12/14/1995 | CA2191436A1 Stable reverse and multiple fluorocarbon emulsions |
12/14/1995 | CA2191362A1 Nucleic acid immunization using a virus-based infection/transfection system |
12/14/1995 | CA2191239A1 Diphtheria toxin vaccines bearing a mutated r domain |
12/14/1995 | CA2190181A1 Starch acetate composition with modifiable properties, method for preparation and usage thereof |
12/13/1995 | EP0686399A1 Powdery pharmaceutical preparation and method of manufacturing same |
12/13/1995 | EP0686391A1 Surfactant-free water-in-oil emulsion |
12/13/1995 | EP0686203A1 Compounds and methods for the diagnosis, treatment and prevention of diseases of cell death |